Plasma derivative · BLA
Aralast NP (Alpha-1-proteinase inhibitor (human)) NDC 0944-2814
Kit · Takeda Pharmaceuticals America, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0944-2814-01 | 0094428140100944281401 | 1 KIT in 1 CARTON (0944-2814-01) * 25 mL in 1 VIAL, GLASS (64764-518-25) * 25 mL in 1 VIAL (0944-2803-03)Marketed from Dec 23, 2002 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aralast NPSuffix: NP
- Generic name (nonproprietary)
- alpha-1-proteinase inhibitor (human)
- Dosage form
- Kit
- Labeler
- Takeda Pharmaceuticals America, Inc.NDC labeler code 0944
- Product type
- Plasma derivative
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125039
- Marketing start
- Listing expires
- Identifiers
- Product ID 0944-2814_20ede125-2505-4088-8f5e-c6d2d5c7c80aSPL ID 20ede125-2505-4088-8f5e-c6d2d5c7c80a
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400944281401followed by a unit qualifier and the quantityPackage 00944-2814-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0944-2814
- What is NDC 0944-2814?
- 0944-2814 is the product NDC for Aralast NP (alpha-1-proteinase inhibitor (human)) kit, listed with the FDA by Takeda Pharmaceuticals America, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Aralast NP (Alpha-1-Proteinase Inhibitor (Human)).
- Who is the labeler?
- Takeda Pharmaceuticals America, Inc., NDC labeler code 0944. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Aralast NP?
- 1 other product NDC are listed under this name. See all Aralast NP NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Aralast NP products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Aralast NPalpha-1-proteinase inhibitor (human) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-2815 | 00944-2815-01 |
Other NDCs under BLA 125039
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aralast NPalpha-1-proteinase inhibitor (human) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-2815 |